HIF1A induces expression of the WASF3 metastasis-associated gene under hypoxic conditions

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The WASF3 (WAVE3) gene is an important mediator of cell motility, invasion and metastasis and is expressed at high levels in some advanced stage tumors. In our survey of breast cancer cells, we now demonstrate that exposure to hypoxic conditions increases WASF3 expression levels in MDA231, SKBR3 and MCF7 cells. The WASF3 promoter region contains HIF1A response elements (HRE). ChIP assays demonstrate that HIF1A binds to these HRE elements in the promoter region, and luciferase reporter assays using the WASF3 gene minimal promoter shows that hypoxia results in its upregulation. Phosphorylation of WASF3 is required for its ability to affect invasion and increased phosphoactivation of WASF3 is also seen in cells challenged with hypoxia. These cells also show increased motility in the scratch wound assay. Cells in which WASF3 has been knocked down show no response to hypoxia as expected, implicating the specificity of the hypoxic response to WASF3. Overall, these experiments demonstrate WASF3 is a HIF1A-regulated gene and suggests a mechanism to explain the observation of elevated expression of WASF3 in advanced stage tumors.

Original languageEnglish (US)
JournalInternational Journal of Cancer
Volume131
Issue number6
DOIs
StatePublished - Sep 15 2012

Fingerprint

Neoplasm Metastasis
Response Elements
Genetic Promoter Regions
Genes
MCF-7 Cells
Luciferases
Cell Movement
Neoplasms
Up-Regulation
Phosphorylation
Observation
Breast Neoplasms
Wounds and Injuries
Hypoxia
Surveys and Questionnaires

Keywords

  • HIF1A
  • WASF3
  • hypoxia
  • invasion

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{95da2967dfd8461299ac56a7c48907d6,
title = "HIF1A induces expression of the WASF3 metastasis-associated gene under hypoxic conditions",
abstract = "The WASF3 (WAVE3) gene is an important mediator of cell motility, invasion and metastasis and is expressed at high levels in some advanced stage tumors. In our survey of breast cancer cells, we now demonstrate that exposure to hypoxic conditions increases WASF3 expression levels in MDA231, SKBR3 and MCF7 cells. The WASF3 promoter region contains HIF1A response elements (HRE). ChIP assays demonstrate that HIF1A binds to these HRE elements in the promoter region, and luciferase reporter assays using the WASF3 gene minimal promoter shows that hypoxia results in its upregulation. Phosphorylation of WASF3 is required for its ability to affect invasion and increased phosphoactivation of WASF3 is also seen in cells challenged with hypoxia. These cells also show increased motility in the scratch wound assay. Cells in which WASF3 has been knocked down show no response to hypoxia as expected, implicating the specificity of the hypoxic response to WASF3. Overall, these experiments demonstrate WASF3 is a HIF1A-regulated gene and suggests a mechanism to explain the observation of elevated expression of WASF3 in advanced stage tumors.",
keywords = "HIF1A, WASF3, hypoxia, invasion",
author = "Pushpankur Ghoshal and Yong Teng and Lesoon, {Leslie Ann} and Cowell, {John Kenneth}",
year = "2012",
month = "9",
day = "15",
doi = "10.1002/ijc.27631",
language = "English (US)",
volume = "131",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - HIF1A induces expression of the WASF3 metastasis-associated gene under hypoxic conditions

AU - Ghoshal, Pushpankur

AU - Teng, Yong

AU - Lesoon, Leslie Ann

AU - Cowell, John Kenneth

PY - 2012/9/15

Y1 - 2012/9/15

N2 - The WASF3 (WAVE3) gene is an important mediator of cell motility, invasion and metastasis and is expressed at high levels in some advanced stage tumors. In our survey of breast cancer cells, we now demonstrate that exposure to hypoxic conditions increases WASF3 expression levels in MDA231, SKBR3 and MCF7 cells. The WASF3 promoter region contains HIF1A response elements (HRE). ChIP assays demonstrate that HIF1A binds to these HRE elements in the promoter region, and luciferase reporter assays using the WASF3 gene minimal promoter shows that hypoxia results in its upregulation. Phosphorylation of WASF3 is required for its ability to affect invasion and increased phosphoactivation of WASF3 is also seen in cells challenged with hypoxia. These cells also show increased motility in the scratch wound assay. Cells in which WASF3 has been knocked down show no response to hypoxia as expected, implicating the specificity of the hypoxic response to WASF3. Overall, these experiments demonstrate WASF3 is a HIF1A-regulated gene and suggests a mechanism to explain the observation of elevated expression of WASF3 in advanced stage tumors.

AB - The WASF3 (WAVE3) gene is an important mediator of cell motility, invasion and metastasis and is expressed at high levels in some advanced stage tumors. In our survey of breast cancer cells, we now demonstrate that exposure to hypoxic conditions increases WASF3 expression levels in MDA231, SKBR3 and MCF7 cells. The WASF3 promoter region contains HIF1A response elements (HRE). ChIP assays demonstrate that HIF1A binds to these HRE elements in the promoter region, and luciferase reporter assays using the WASF3 gene minimal promoter shows that hypoxia results in its upregulation. Phosphorylation of WASF3 is required for its ability to affect invasion and increased phosphoactivation of WASF3 is also seen in cells challenged with hypoxia. These cells also show increased motility in the scratch wound assay. Cells in which WASF3 has been knocked down show no response to hypoxia as expected, implicating the specificity of the hypoxic response to WASF3. Overall, these experiments demonstrate WASF3 is a HIF1A-regulated gene and suggests a mechanism to explain the observation of elevated expression of WASF3 in advanced stage tumors.

KW - HIF1A

KW - WASF3

KW - hypoxia

KW - invasion

UR - http://www.scopus.com/inward/record.url?scp=84864148070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864148070&partnerID=8YFLogxK

U2 - 10.1002/ijc.27631

DO - 10.1002/ijc.27631

M3 - Article

C2 - 22581642

AN - SCOPUS:84864148070

VL - 131

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 6

ER -